Vice Chairlady of the Board & CEO Qian Li Just Bought Shares In Consun Pharmaceutical Group Limited (HKG:1681)

Consun Pharmaceutical Group Limited (HKG:1681) shareholders (or potential shareholders) will be happy to see that the Vice Chairlady of the Board & CEO, Qian Li, recently bought a whopping HK$4.2m worth of stock, at a price of HK$3.26. While that only increased their holding size by 1.0%, it is still a big swing by our standards.

View our latest analysis for Consun Pharmaceutical Group

Consun Pharmaceutical Group Insider Transactions Over The Last Year

In fact, the recent purchase by Qian Li was the biggest purchase of Consun Pharmaceutical Group shares made by an insider individual in the last twelve months, according to our records. That implies that an insider found the current price of HK$3.38 per share to be enticing. Of course they may have changed their mind. But this suggests they are optimistic. We do always like to see insider buying, but it is worth noting if those purchases were made at well below today’s share price, as the discount to value may have narrowed with the rising price. The good news for Consun Pharmaceutical Group share holders is that an insider was buying at near the current price. Qian Li was the only individual insider to buy over the year.

Qian Li purchased 2.57m shares over the year. The average price per share was HK$3.64. The chart below shows insider transactions (by individuals) over the last year. By clicking on the graph below, you can see the precise details of each insider transaction!

SEHK:1681 Recent Insider Trading March 27th 2020
SEHK:1681 Recent Insider Trading March 27th 2020

Consun Pharmaceutical Group is not the only stock that insiders are buying. For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.

Insider Ownership

Many investors like to check how much of a company is owned by insiders. A high insider ownership often makes company leadership more mindful of shareholder interests. Consun Pharmaceutical Group insiders own 55% of the company, currently worth about HK$1.5b based on the recent share price. Most shareholders would be happy to see this sort of insider ownership, since it suggests that management incentives are well aligned with other shareholders.

So What Does This Data Suggest About Consun Pharmaceutical Group Insiders?

The recent insider purchase is heartening. And the longer term insider transactions also give us confidence. When combined with notable insider ownership, these factors suggest Consun Pharmaceutical Group insiders are well aligned, and quite possibly think the share price is too low. Nice! In addition to knowing about insider transactions going on, it’s beneficial to identify the risks facing Consun Pharmaceutical Group. For example – Consun Pharmaceutical Group has 4 warning signs we think you should be aware of.

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.